we have several drugs in trials. By the end of next year we should know if one, 2 or 3 of them work, and a path to market well defined and possibly also in a deal. I would be bold enough to suggest if all 3 go well then the SP could be of the order of $3.50 without too much trouble. I am on the ship, if you think that a 3x in 18 months isn a rocket feel free to risk some of your own money. I cant find a company with better prospects so ‘I’m IN” Happy Easter. Over and out, see you in 18mo.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)